Clinical Trial Update: VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV [Phase 4]

View source ↗

Summary

Phase 4 trial updating vaccination of plasma donors for production of VIGIV related to smallpox vaccine adverse reactions; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox Vaccine Adverse Reaction

Drugs mentioned

• ACAM2000 (Vaccinia vaccine (live, cell culture-derived))
• VIGIV (Vaccinia immune globulin intravenous)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Smallpox Vaccine Adverse Reaction | Phase 4 | Status: COMPLETED | Results posted: 2022-10-26